Furthermore, the ADORA3 antagonism has the potential to block renal fibrosis in diabetic rats, since the distribution of the pro-fibrotic marker α-SMA was markedly decreased at the renal level, mainly at the tubulointertitium (Figure 6A,B). Here, ADORA3 is linked to renal fibrosis.